Salvatore Petta1, Mohammed Eslam2, Luca Valenti3, Elisabetta Bugianesi4, Marco Barbara1, Calogero Cammà1, Marianna Porzio3, Chiara Rosso4, Silvia Fargion3, Jacob George2, Antonio Craxì1. 1. Section of Gastroenterology, Dipartimento Biomedico di Medicina Interna e Specialistica, University of Palermo, Palermo, Italy. 2. Storr Liver Unit, Westmead Millennium Institute and Westmead Hospital, University of Sydney, Sydney, NSW, Australia. 3. Department of Pathophysiology and Transplantation, Università degli Studi, Internal Medicine, Fondazione Ca' Granda IRCCS Ospedale Maggiore Policlinico, Milano, Italy. 4. Division of Gastro-Hepatology, Department of Medical Sciences, San Giovanni Battista Hospital, University of Torino, Torino, Italy.
Abstract
BACKGROUND & AIMS: Metabolic syndrome (MS) and its individual components are associated with the severity and progression of nonalcoholic fatty liver disease (NAFLD). We sought to evaluate the relationship between MS components and the risk of severe hepatic fibrosis in NAFLD patients discriminated by age. METHODS: We considered 863 consecutive patients with biopsy-proven NAFLD, who had been fully evaluated for components of MS. RESULTS: Multivariate logistic regression analysis showed that F3-F4 was associated with visceral obesity, IFG/diabetes, and low high-density lipoprotein (HDL) cholesterol, but not triglycerides >150 or arterial hypertension. A significant interaction was found between age and visceral obesity (P=.04). By stratifying patients for age, we confirmed the interaction between inclusion in the third age tertile (>54 years) and visceral obesity (P=.04). In the lower (<41 years) and middle (41-54 years) age tertiles, the risk for F3-F4 fibrosis was mostly driven by visceral obesity and IFG/diabetes. This risk was higher in those with all three metabolic risk factors. Finally, among patients in the higher age tertile (>54 years), obesity did not affect the severity of fibrosis, and the risk of severe fibrosis was higher in those with low HDL and IFG/diabetes with/without visceral obesity (52%-54%). CONCLUSIONS: Among patients with NAFLD, the metabolic profiles associated with risk for severe fibrosis varied among age groups. Low HDL, obesity and IFG/diabetes were prevalent among patients in the lower and middle age tertiles. HDL and IFG/diabetes but not visceral obesity were prevalent among those in the highest age tertile.
BACKGROUND & AIMS:Metabolic syndrome (MS) and its individual components are associated with the severity and progression of nonalcoholic fatty liver disease (NAFLD). We sought to evaluate the relationship between MS components and the risk of severe hepatic fibrosis in NAFLD patients discriminated by age. METHODS: We considered 863 consecutive patients with biopsy-proven NAFLD, who had been fully evaluated for components of MS. RESULTS: Multivariate logistic regression analysis showed that F3-F4 was associated with visceral obesity, IFG/diabetes, and low high-density lipoprotein (HDL) cholesterol, but not triglycerides >150 or arterial hypertension. A significant interaction was found between age and visceral obesity (P=.04). By stratifying patients for age, we confirmed the interaction between inclusion in the third age tertile (>54 years) and visceral obesity (P=.04). In the lower (<41 years) and middle (41-54 years) age tertiles, the risk for F3-F4 fibrosis was mostly driven by visceral obesity and IFG/diabetes. This risk was higher in those with all three metabolic risk factors. Finally, among patients in the higher age tertile (>54 years), obesity did not affect the severity of fibrosis, and the risk of severe fibrosis was higher in those with low HDL and IFG/diabetes with/without visceral obesity (52%-54%). CONCLUSIONS: Among patients with NAFLD, the metabolic profiles associated with risk for severe fibrosis varied among age groups. Low HDL, obesity and IFG/diabetes were prevalent among patients in the lower and middle age tertiles. HDL and IFG/diabetes but not visceral obesity were prevalent among those in the highest age tertile.
Authors: Jongsin Park; Heon-Ju Kwon; Won Sohn; Ju-Yeon Cho; Soo Jin Park; Yoosoo Chang; Seungho Ryu; Byung Ik Kim; Yong Kyun Cho Journal: PLoS One Date: 2022-06-02 Impact factor: 3.752
Authors: Mircea Vasile Milaciu; Lorena Ciumărnean; Daniela Maria Matei; Ștefan Cristian Vesa; Octavia Sabin; Ioana Corina Bocșan; Raluca Maria Pop; Vasile Negrean; Anca Dana Buzoianu; Monica Acalovschi Journal: Exp Ther Med Date: 2021-03-23 Impact factor: 2.447
Authors: Chen Huanan; Li Sangsang; Adwoa Nyantakyiwaa Amoah; Bo Yacong; Chen Xuejiao; Shi Zhan; Wan Guodong; Huang Jian; Shi Songhe; Lyu Quanjun Journal: BMJ Open Date: 2020-11-27 Impact factor: 2.692
Authors: Omar A Saldarriaga; Bradley Dye; Judy Pham; Timothy G Wanninger; Daniel Millian; Michael Kueht; Benjamin Freiberg; Netanya Utay; Heather L Stevenson Journal: Sci Rep Date: 2021-07-15 Impact factor: 4.379